Saputo (SAP) Scheduled to Post Earnings on Thursday
by Amy Steele · The Cerbat GemSaputo (TSE:SAP – Get Free Report) is set to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of C$0.39 per share for the quarter.
Saputo (TSE:SAP – Get Free Report) last released its quarterly earnings results on Thursday, August 8th. The company reported C$0.39 earnings per share for the quarter, beating the consensus estimate of C$0.37 by C$0.02. The company had revenue of C$4.61 billion for the quarter, compared to analyst estimates of C$4.44 billion. Saputo had a return on equity of 3.72% and a net margin of 1.50%.
Saputo Stock Down 1.3 %
Shares of SAP opened at C$26.52 on Tuesday. The company has a quick ratio of 0.67, a current ratio of 1.59 and a debt-to-equity ratio of 53.17. Saputo has a 52-week low of C$25.28 and a 52-week high of C$32.15. The company has a market cap of C$11.25 billion, a PE ratio of 42.10, a P/E/G ratio of 0.56 and a beta of 0.32. The business has a fifty day moving average of C$28.76 and a 200 day moving average of C$29.03.
Saputo Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 20th. Investors of record on Friday, September 20th were paid a dividend of $0.19 per share. The ex-dividend date was Tuesday, September 10th. This is a boost from Saputo’s previous quarterly dividend of $0.19. This represents a $0.76 dividend on an annualized basis and a dividend yield of 2.87%. Saputo’s payout ratio is currently 120.63%.
Analyst Upgrades and Downgrades
Several analysts have issued reports on the stock. BMO Capital Markets downgraded shares of Saputo from an “outperform” rating to a “market perform” rating and decreased their price objective for the stock from C$35.00 to C$30.00 in a research note on Tuesday, October 15th. CIBC decreased their price target on Saputo from C$37.00 to C$35.00 and set an “outperform” rating for the company in a research note on Monday, August 12th. Royal Bank of Canada cut their price objective on Saputo from C$39.00 to C$38.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 29th. Finally, National Bankshares decreased their target price on Saputo from C$36.00 to C$35.00 and set an “outperform” rating for the company in a research report on Monday, August 12th. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of C$34.64.
Get Our Latest Research Report on Saputo
Insiders Place Their Bets
In other Saputo news, Senior Officer Carl Colizza acquired 6,800 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The shares were bought at an average cost of C$29.43 per share, with a total value of C$200,124.00. In other news, Senior Officer Martin Gagnon purchased 2,000 shares of the firm’s stock in a transaction on Tuesday, August 20th. The stock was acquired at an average cost of C$29.73 per share, with a total value of C$59,450.00. Also, Senior Officer Carl Colizza purchased 6,800 shares of the stock in a transaction dated Tuesday, August 13th. The stock was purchased at an average price of C$29.43 per share, for a total transaction of C$200,124.00. 40.45% of the stock is owned by company insiders.
About Saputo
Saputo Inc produces, markets, and distributes dairy products in Canada, the United States, Argentina, Australia, and the United Kingdom. The company offers cheeses, including mozzarella and cheddar; specialty cheeses, such as ricotta, provolone, blue, parmesan, goat cheese, feta, romano, and havarti; fine cheeses comprising brie and camembert; and other cheeses that include brick, colby, farmer, munster, monterey jack, fresh curd, and processed cheeses.
Featured Stories
- Five stocks we like better than Saputo
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Intel: Is Now the Time to Be Brave?
- What does consumer price index measure?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Insider Trades May Not Tell You What You Think
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?